These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18408925)

  • 1. Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.
    Schmidt MM; Thurber GM; Wittrup KD
    Cancer Immunol Immunother; 2008 Dec; 57(12):1879-90. PubMed ID: 18408925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and kinetic analysis of recombinant anti-CEA antibody fragments.
    Abraham R; Buxbaum S; Link J; Smith R; Venti C; Darsley M
    J Immunol Methods; 1995 Jun; 183(1):119-25. PubMed ID: 7602129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
    Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
    Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
    Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
    Kenanova V; Olafsen T; Crow DM; Sundaresan G; Subbarayan M; Carter NH; Ikle DN; Yazaki PJ; Chatziioannou AF; Gambhir SS; Williams LE; Shively JE; Colcher D; Raubitschek AA; Wu AM
    Cancer Res; 2005 Jan; 65(2):622-31. PubMed ID: 15695407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.
    Hefta LJ; Neumaier M; Shively JE
    Immunotechnology; 1998 Jun; 4(1):49-57. PubMed ID: 9661814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human monoclonal igA antibody against CEA to recruit neutrophils to CEA-expressing cells.
    Zhao J; Kuroki M; Shibaguchi H; Wang L; Huo Q; Takami N; Tanaka T; Kinugasa T; Kuroki M
    Oncol Res; 2008; 17(5):217-22. PubMed ID: 18980018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.
    Thurber GM; Wittrup KD
    Cancer Res; 2008 May; 68(9):3334-41. PubMed ID: 18451160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.